Prenoxad: first opioid antidote for non-clinician use

2 June 2013

Martindale has launched Prenoxad (naloxone), the first licensed opioid overdose treatment for use by non-healthcare professionals in the community setting.

Prenoxad is administered intramuscularly into the outer thigh or upper arm and is intended for emergency use in the home or other non-medical setting.

Supplied in a kit containing a pre-filled syringe and two needles, Prenoxad (naloxone) is licensed for emergency use to reverse life-threatening respiratory depression caused by natural or synthetic opioids. It should be administered by intramuscular injection as part of a resuscitation intervention.

Prenoxad is intended to be carried by individuals at risk of opioid overdose. Prescribers must assess the competence of the patient or representative to administer the product in the appropriate circumstances.

View Prenoxad drug record

Further information: Martindale

Follow MIMS on Twitter